临床试验/NCT06702111

NCT06702111招募中不适用

Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Adults: Clinical Outcome and Complications

The University of Hong Kong2 个研究点分布在 1 个国家目标入组 1,000 人开始时间: 2024年12月最近更新: 2024年11月27日

适应症

试验速览

阶段: 不适用
状态: 招募中
发起方: The University of Hong Kong
入组人数: 1,000
试验地点: 2
主要终点: Overall survival

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

To collect baseline and outcome data relating to all bone marrow, peripheral blood, cord blood hematopoietic stem cell transplants and therapies related to hematopoietic stem cell transplantation performed in Queen Mary Hospital.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Other

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Adult patients aged 18 years or older who received allogeneic hematopoietic stem cell transplantation (allo-HSCT).

排除标准

•participant who is unable to give informed consent in a prospective cohort.

结局指标

主要结局

Overall survival

时间窗: 5 year

Time from HSCT to death or latest follow-up

Relapse-free survival

时间窗: 5 years

Time from HSCT to relapse, death or latest follow-up

次要结局

未报告次要终点

研究者

发起方

The University of Hong Kong

申办方类型

Other

责任方

Sponsor

研究点 (2)

Loading locations...

相似试验

Unknown

不适用

Graft-versus-host Disease Associated MyelosuppressionAbnormal HematopoiesisAllogenic DiseaseGraft vs Host Disease

NCT02829216Technische Universität Dresden50

招募中

不适用

Allogeneic Hematopoietic Stem Cell Transplantation Cohort StudyAllogeneic Hematopoietic Stem Cell Transplantation

NCT06708130Ruijin Hospital3,000

终止

不适用

Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell TransplantationAcute Myelogenous LeukemiaHodgkins LymphomaNon-Hodgkins LymphomaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia

NCT01326728National Cancer Institute (NCI)56

尚未招募

不适用

Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell TransplantionHematopoietic Stem Cell TransplantationMicrobioataRespiratory Complications

NCT06639750University Hospital, Caen120

终止

不适用

Stem Cell Transplant for Hematological MalignancyLeukemia, Myeloid, ChronicLeukemia, Lymphocytic, AcuteMDSLeukemia, Lymphocytic, ChronicHodgkin's DiseaseNon-hodgkin's LymphomaMultiple MyelomaJMMLAML

NCT00176930Masonic Cancer Center, University of Minnesota330